Liberation From Acute Dialysis (NCT04218370) | Clinical Trial Compass
CompletedNot Applicable
Liberation From Acute Dialysis
United States220 participantsStarted 2020-01-23
Plain-language summary
The goal of the LIBERATE-D clinical trial is to improve outcomes for patients recovering from dialysis-requiring acute kidney injury (AKI-D). The impact of a conservative dialysis strategy compared to standard clinical practice of thrice-weekly dialysis will be examined to help generate knowledge for how to guide delivery of dialysis to facilitate renal recovery.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ≥ 18 years of age
* Inpatient with AKI-D (intermittent hemodialysis or continuous renal replacement therapy received on at least one calendar day) at least partially due t acute tubular necrosis per the clinical nephrology team
* Hemodynamic stability: not requiring vasopressor support and with planned intermittent dialysis
* Baseline estimated glomerular filtration rate (eGFR) ≥ 15 mL/min/1.73 m2
Exclusion Criteria:
* Nontraditional indication for dialysis (end-stage liver disease awaiting transplantation, fulminant hepatic failure, intoxication)
* Complete nephrectomy as cause of AKI-D
* Kidney transplant during index hospitalization
* Dialysis \> 3 months
* Decompensated heart failure requiring left ventricular assist device or continuous inotropic support
* Mechanical ventilation via endotracheal tube
* Hypoxemia requiring significant oxygen support: \>5 liters/min via nasal cannula or equivalent via face mask/tracheostomy mask to maintain oxygen saturation \> 95%, or requiring fraction of inspired oxygen \>50% in patients with tracheostomy requiring invasive or non-invasive ventilation
* Unable to consent and no surrogate decisionmaker available
* Pregnant
* Prisoner
* Clinical team declines to allow study participation
* Anticipated discharge or transfer from study hospital within 48 hours
What they're measuring
1
Proportion of patients with renal recovery at hospital discharge
Timeframe: Up to 14 days after hospital discharge (to allow for ascertainment of outcome at hospital discharge, which requires a period of sustained dialysis independence)